Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
SS Innovation Merges With Avra Medical Robotics
SS Innovation has merged with Avra Medical Robotics. Orlando, Florida-based Avra Medical Robotics develops and manufactures surgical devices. It offers surgical robotic systems, surgical tools, implantable devices and surgical robotic training. The company develops a treatment-independent autonomous robotics system to deliver skin resurfacing treatments, such as micro-needling and laser therapies. The company was formerly known as Avra Surgical Microsystems and changed its name to Avra Medical Robotics in November 2015. SS Innovation is an Indian medtech startup founded by Dr. Sudhir Srivastava in 2016. The company aims to provide an advanced, cost-effective surgical robotic system through... Read More »
Cambrex Acquires Snapdragon Chemistry
East Rutherford, New Jersey-based Cambrex Corporation has acquired Snapdragon Chemistry of Waltham, Massachusetts. Snapdragon specializes in active pharmaceutical ingredient (API) batch and continuous flow process development, utilizing automation technology and proprietary equipment to solve complex process and analytical development challenges. Cambrex is a global contract development and manufacturing organization (CDMO) that provides drug substance, drug product and analytical services across the entire drug lifecycle. The transaction is expected to close following the completion of customary regulatory approvals. This will be Cambrex’s second acquisition within a year along with... Read More »
Uniphar Acquires BModesto Group
Uniphar PLC (LON: UPR) announced its acquisition of BModesto Group on November 21 for nearly $52.3 million. Founded in 2014, BModesto Group is a Dutch healthcare services firm. It offers a range of services, including the distribution of medicines, clinical trial services, market authorization holder services and medical device distribution. In 2021, it reported $7,890,498 in revenue (€7.7 million). Uniphar is a pharmaceutical manufacturing and healthcare services organization with offices in Ireland, England and the U.S. The company was founded in 1967 and is based in Dublin, Ireland. In 2021, Uniphar generated revenue of $1,946,977,500 (€1.9 billion), gross profit of $281,287,012... Read More »
MB2 Dental Solutions Acquires Maryland Practice, Celebrates 500th Acquisition
MB2 Dental Solutions announced on November 18 that it completed its 500th partnership with its acquisition of Dr. Pattanashetti, DMD Cosmetic, Implant, & General Dentistry. The practice of Dr. Pattanashetti, DMD Cosmetic, Implant, & General Dentistry is located in Towson, Maryland and is run by one dentist. MB2 Dental Solutions, a portfolio company of middle-market private equity firm Charlesbank Capital Partners since February 2021, partners with dentists and specialists. Founded in 2007, MB2 offers general dentistry services, orthodontics, cosmetic dentistry and oral surgery. This acquisition represents MB2 Dental’s 37th acquisition of the year. The terms of the... Read More »
PhyNet Dermatology acquires Dermatology Center of Dallas
PhyNet Dermatology, a portfolio company of Century Equity Partners, announced its acquisition of Dermatology Center of Dallas. This acquisition represents PhyNet Dermatology’s third transaction of the year. Dermatology Center of Dallas has one location in Dallas, Texas and is run by two providers. It was founded in 2001. PhyNet Dermatology LLC is a dermatology practice management company headquartered in Franklin, Tennessee. With more than 100 locations in 17 states across the United States, PhyNet Dermatology offers administrative management and support that enables physicians to focus their efforts on providing patient care. With the acquisition, Dermatology Center of Dallas... Read More »
Merck Acquires Imago BioSciences for $1.35 Billion
Merck & Co., Inc. has entered into a definitive agreement under which Merck, through a subsidiary, will acquire Imago BioSciences, Inc. for $36.00 per share in cash for an approximate total equity value of $1.35 billion. The transaction is expected to close in the first quarter of 2023. Morgan Stanley & Co. LLC is acting as financial advisor to Merck in this transaction and Gibson, Dunn & Crutcher LLP as its legal advisors. Centerview Partners is acting as financial advisor to Imago and Latham & Watkins LLP as its legal advisors. Imago BioSciences is a clinical stage biopharmaceutical company developing medicines for the treatment of myeloproliferative neoplasms and other... Read More »
Gundersen Health System, Bellin Health to Merge
After six months of negotiations, two Wisconsin-based health systems, Gundersen Health System and Bellin Health, have announced a merger agreement and expect to combine operations by December 1. The merger will create one of the largest health systems in the Midwest. Bellin Health is an integrated healthcare delivery system established in 1908 and based in Green Bay, Wisconsin. It has more than 5,000 employees and offers services in cardiac, orthopedics, sports medicine, digestive health, mental health and primary care medicine. It comprises Bellin Hospital (167 beds), Bellin Psychiatric Center, 29 Bellin Health primary and specialty care physician clinics and retail health clinics known... Read More »
Reverie Mind Acquires Arizona Ketamine Treatment and Research Institute
Reverie Mind has acquired the Arizona Ketamine Treatment and Research Institute. Located in the Arizona State University Research Park in Tempe, Arizona, Ketamine Treatment and Research Institute (AKTARI) provides ketamine treatment for depression, bipolar disorder, OCD, anxiety, PTSD, panic disorder, alcohol abuse and opiate addiction. Reverie Mind, also based in Tempe, Arizona, is a psychedelic clinic and research organization for mental wellness services and coordinated clinical trials. Reverie’s clinics are designed to provide qualified individuals access to plant-based therapies, special access programs, traditional therapy options and clinical trials focused on psychedelic... Read More »
Beyond Podiatry Acquires Cincinnati Foot & Ankle Care
Beyond Podiatry, a portfolio company of private equity firm Albaron Partners, LP., has acquired Cincinnati Foot & Ankle Care. Founded in 1998, Cincinnati Foot & Ankle Care is a podiatry practice of foot and ankle surgeons committed to providing care for all types of foot and ankle injuries and conditions. Cincinnati Foot & Ankle Care has 19 foot and ankle surgeons providing care at 18 locations across southwest Ohio. Clinton Township, Michigan-based Beyond Podiatry is one of the largest podiatry practice management organizations in the Midwest. Terms of the transaction were not disclosed. According to the LevinPro HC database, this was the 17th podiatry practice transaction of... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
